Positioning Statements and documents

Statement on Compounded (Bioidentical) Menopausal Hormone Therapy

231020 FINAL The South African Menopause Society (SAMS) Statement on Compounded (Bioidentical) Menopausal Hormone Therapy, 18 October, 2023

September 23, 2024

The South African Menopause Society (SAMS) Statement on Compounded (Bioidentical) Menopausal Hormone Therapy, 18 October, 2023

SAMS CMHT guidelines final October 202 This statement from the South African Menopause Society (SAMS) is written as an advisory for healthcare practitioners due to concerns about the widespread use

February 2, 2024

Statement on Compounded (Bioidentical) Menopausal Hormone Therapy

231020 The South African Menopause Society (SAMS) Statement on Compounded (Bioidentical) Menopausal Hormone Therapy, 18 October, 2023

October 31, 2023

The Collaborative Group on Hormonal Factors in Breast Cancer reported results of their study published in the Lancet

November 20, 2019

08 BMS Tool for Clinician Testosterone replacement in menopause 02D

November 20, 2019

Lancet Menopause HRT Breast Cancer

August 29, 2019

29.8.19 IMS statement menopausal hormone therapy Lancet

August 29, 2019